Navigation Links
Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices

DUBLIN, Calif., Aug. 23 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) and TEC Edmonton have entered into an exclusive patent license agreement that allows MBI to commercialize a University of Alberta invention that can improve the development of lab-on-a-chip devices and biosampling procedures.

"The licensing of this fundamental patent on manipulating beads on-chip continues to build upon our strong intellectual property position in microfluidic devices," said Stevan Jovanovich, President and CEO of MBI. "Microfluidic devices will play a critical role in next generation instrumentation in delivering fully automated, cost effective solutions life science, applied sciences, and diagnostic products for laboratory and field based applications."

California-based MBI will use the technology patented by TEC Edmonton officially called an Apparatus and Method for Trapping Bead Based Reagents within Microfluidic Analysis Systems (US Patent 6,432,290). A team led by Dr. Jed Harrison, Professor and Chair in the Department of Chemistry, invented the technology to allow trapping of beads on-chip, as well as packing and unpacking the trapping zones, which significantly extends the applications of microfluidic analysis systems, such as those used in biodefense and genomics industries.

Microfluidics deals with the behavior, precise control and manipulation of microliter and nanoliter volumes of fluids and is used in the development of devices such as DNA chips, micro-propulsion, and lab-on-a-chip technology. Microfluidic devices are smaller, faster and cheaper than the desktop counterparts that they are designed to replace.

About TEC Edmonton

TEC Edmonton acts as the exclusive technology transfer office for the University of Alberta, the largest research institution in the province of Alberta with nearly 13,000 academic and support staff and over 36,000 students at its campus in the Province's capital, Edmonton. A joint venture of the University of Alberta and Edmonton Economic Development Corporation, TEC Edmonton is committed to providing investors with access to high-growth, advanced-technology opportunities in the form of new inventions, innovations, or early stage ventures created in the Edmonton region. For more information, visit:

About Microchip Biotechnologies

Microchip Biotechnologies Inc. is an early-stage privately-held company located in Dublin, California that is developing advanced nanofluidic sample preparation and analytical instrumentation for Life Sciences, Applied Sciences, and Diagnostics markets. These solutions are based on MBI's proprietary "NanoBioProcessorTM platform and associated "Microscale-on-Chip-Valves" (MOVTM). More details can be found on the Company's website:

SOURCE Microchip Biotechnologies
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
2. Perscitus Biosciences secures $250K Commerce loan
3. ProCertus BioPharm secures $2.3M in financing
4. Mirus Bio secures $900K grant to develop research tool
5. BioSystem Development secures angel funding
6. TrafficCast secures $1 million line of credit
7. Medical College secures $9.7M research grant
8. Wausau start up secures $560K for GPS maps
9. Platypus Technologies secures $450K SBIR grant
10. nPoint Secures Second Round of Funding
11. Congresswoman Baldwin secures Federal Funds for UW-Rock County
Post Your Comments:
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):